NCT03880981

Brief Summary

Rationale: The Emergency Department (ED) typically serves as the front line for patients with acute fractures and tendon ruptures. Pain control for these patients is an essential task of the ED physician. With the advent of the opioid epidemic, ED physicians are becoming more inclined to prescribe non-narcotic pain medications such as non-steroidal anti-inflammatory drugs (NSAIDs). Yet, the effects of NSAIDs on musculoskeletal healing are controversial. The few human studies examining the effects of NSAID use on fracture healing have provided conflicting results. Even less is known about the effects of NSAIDs on tendon healing as this information has largely been gleaned from rodent studies with contradictory findings. There has never been a large, prospective, randomized, double-blinded study to determine the effects of NSAIDs on healing after fractures or tendon ruptures. Here, I propose to pilot the first prospective, randomized, double-blinded study examining the effects of NSAID use on healing after tibia fractures and Achilles tendon ruptures. Aim 1 seeks to determine whether NSAID use is associated with an increased incidence of fracture nonunion and worse functional recovery six months following tibia fractures. I hypothesize that NSAID use after tibia fractures will be associated with an increased incidence of fracture nonunion and worse functional recovery. Aim 2 seeks to determine whether NSAID use is associated with worse functional recovery six months after Achilles tendon ruptures. I hypothesize that NSAID use after Achilles tendon ruptures will be associated with worse functional recovery. Significance: Emergency Department providers commonly prescribe NSAIDs for pain control following fractures and tendon injuries. However, the implications of this practice on bone and tendon healing are unknown. This proposal will pilot the first prospective, randomized, double-blinded study to determine whether NSAID use affects healing after tibia fractures and Achilles tendon ruptures. Results from this study will impact NSAID prescribing patterns for tibia fractures and Achilles tendon ruptures in the ED, either by demonstrating that they impair recovery and should be avoided, or that they need not be withheld as an effective non-narcotic form of pain control.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
456

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2019

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 22, 2019

Completed
25 days until next milestone

First Posted

Study publicly available on registry

March 19, 2019

Completed
5 months until next milestone

Study Start

First participant enrolled

August 1, 2019

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2020

Completed
Last Updated

March 19, 2019

Status Verified

March 1, 2019

Enrollment Period

1 year

First QC Date

February 22, 2019

Last Update Submit

March 17, 2019

Conditions

Keywords

fracturetendon ruptureNSAIDhealing

Outcome Measures

Primary Outcomes (2)

  • Incidence of non-union after tibia fracture

    Fractures

    6 months

  • Functional Recovery after Achilles Tendon Rupture

    Achilles Tendon Total Rupture Score measures functional recovery after Achilles tendon rupture on a scale of 0 (worse) to 100 (best).

    6 months

Secondary Outcomes (2)

  • Functional Impairment after Tibia Fracture on a scale of 1 to 3 (none to severe)

    6 months

  • Degree of pain after Tibia Fracture on a scale of 1-9

    6 months

Study Arms (2)

Acetaminophen

ACTIVE COMPARATOR

Patients will receive 650mg PO Acetaminophen every 6 hours as needed for pain

Drug: Acetaminophen

Ibuprofen

ACTIVE COMPARATOR

Patients will receive 600mg PO Ibuprofen every 6 hours as needed for pain

Drug: Ibuprofen 600 mg

Interventions

ibuprofen 600mg Po q 6 hours prn pain

Ibuprofen

acetaminophen 600mg po q6 hours prn pain

Acetaminophen

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients (over 18) presenting within 24 hours of a tibia fracture
  • Adult patients (over 18) presenting within 24 hours of an Achilles tendon rupture
  • Patients will be excluded if they:
  • have a contraindication to Ibuprofen or Acetaminophen use
  • don't have access to e-mail
  • require emergent surgery (such as an open fracture)
  • have a diagnosis of osteoporosis
  • have already taken one of the study drugs since their injury
  • are pregnant (due to their inability to take NSAIDs)
  • are \< 18 years old (due to differences in bone and tendon healing).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Fractures, Bone

Interventions

IbuprofenAcetaminophen

Condition Hierarchy (Ancestors)

Wounds and Injuries

Intervention Hierarchy (Ancestors)

PhenylpropionatesAcids, CarbocyclicCarboxylic AcidsOrganic ChemicalsAcetanilidesAnilidesAmidesAniline CompoundsAmines

Study Officials

  • Vanessa Franco, MD PhD

    Assistant Professor

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Vanessa Franco, MD PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

February 22, 2019

First Posted

March 19, 2019

Study Start

August 1, 2019

Primary Completion

July 31, 2020

Study Completion

July 31, 2020

Last Updated

March 19, 2019

Record last verified: 2019-03

Data Sharing

IPD Sharing
Will not share